AbbVie (ABBV) Revenue — Quarter Ended Mar 31, 2025
Revenue for the quarter declined compared to the immediately preceding quarter but rose relative to the same quarter one year earlier.
Key takeaway
Quarter ended Mar 31, 2025 · FY2025 Q1
Revenue for the quarter declined compared to the immediately preceding quarter but rose relative to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$13.3B
Revenue reported for this quarter.
Quarter-over-quarter
-11.6%
Change from the immediately preceding quarter.
Year-over-year
+8.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$57.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2024 | $14.5B | +4.3% |
| Sep 30, 2024 | $14.5B | +3.8% |
| Dec 31, 2024 | $15.1B | +5.6% |
| Mar 31, 2025 | $13.3B | +8.4% |
Revenue performance
The reported revenue decreased from the prior quarter, breaking a streak of sequential increases seen in earlier periods.
Quarterly comparison
Compared with the prior quarter, revenue was lower; however, compared with the same quarter a year ago, revenue was higher.
What to watch
The sequential decline in revenue may warrant attention given the prior pattern of quarterly growth.